Form D · Biotechnology
Aria Diagnostics, Inc.
San Jose, CA · CIK 0001493753
Offering snapshot reported Jan 17, 2012 · SEC filing
- Reported sold
- $52.7M Offering amount: $52.7M
- Investors reported
- 26 Form D · investor count
- Minimum accepted
- $1.5K Reported outside-investor minimum
- First sale
- Nov 30, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 17, 2012 | Initial | $52,699,628 | No comparison | 26 | SEC filing |
| Jun 9, 2010 | Initial | $12,500,000 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-171930
A portion of the total amount sold includes conversion of indebtedness.
Source: Form D, filed Jan 17, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kim Kamdar | Director |
| Hallie Mitchell | Executive |
| Michael Mitchell | Director |
| Bryan Roberts | Director |
| Kenneth Song | Director, Executive |
| John Steulpnagel | Director |
| John Stuelpnagel | Director |
| Bill Young | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5945 Optical Court
San Jose, CA, 95138
San Jose, CA, 95138